CompuGroup Medical SE & Co. KGaA

COP.DE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, COP.DE stands at 1.2B. In comparison, VEE.DE has a market cap of 22.3B. Regarding current trading prices, COP.DE is priced at €22.66, while VEE.DE trades at €135.15.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

COP.DE currently has a P/E ratio of 43.58, whereas VEE.DE's P/E ratio is 29.19. In terms of profitability, COP.DE's ROE is +0.01%, compared to VEE.DE's ROE of +0.13%. Regarding short-term risk, COP.DE is more volatile compared to VEE.DE. This indicates potentially higher risk in terms of short-term price fluctuations for COP.DE.Check VEE.DE's competition here

COP.DE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, COP.DE stands at 1.2B. In comparison, QY1.F has a market cap of 1.5B. Regarding current trading prices, COP.DE is priced at €22.66, while QY1.F trades at €22.20.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

COP.DE currently has a P/E ratio of 43.58, whereas QY1.F's P/E ratio is -246.67. In terms of profitability, COP.DE's ROE is +0.01%, compared to QY1.F's ROE of -0.01%. Regarding short-term risk, COP.DE is more volatile compared to QY1.F. This indicates potentially higher risk in terms of short-term price fluctuations for COP.DE.Check QY1.F's competition here

COP.DE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, COP.DE stands at 1.2B. In comparison, NXU.DE has a market cap of 1.2B. Regarding current trading prices, COP.DE is priced at €22.66, while NXU.DE trades at €71.20.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

COP.DE currently has a P/E ratio of 43.58, whereas NXU.DE's P/E ratio is 36.14. In terms of profitability, COP.DE's ROE is +0.01%, compared to NXU.DE's ROE of +0.12%. Regarding short-term risk, COP.DE is more volatile compared to NXU.DE. This indicates potentially higher risk in terms of short-term price fluctuations for COP.DE.Check NXU.DE's competition here

COP.DE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, COP.DE stands at 1.2B. In comparison, 4LL.F has a market cap of 861.7M. Regarding current trading prices, COP.DE is priced at €22.66, while 4LL.F trades at €4.89.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

COP.DE currently has a P/E ratio of 43.58, whereas 4LL.F's P/E ratio is -0.17. In terms of profitability, COP.DE's ROE is +0.01%, compared to 4LL.F's ROE of -0.14%. Regarding short-term risk, COP.DE is more volatile compared to 4LL.F. This indicates potentially higher risk in terms of short-term price fluctuations for COP.DE.Check 4LL.F's competition here

COP.DE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, COP.DE stands at 1.2B. In comparison, AJ91.DE has a market cap of 63.9M. Regarding current trading prices, COP.DE is priced at €22.66, while AJ91.DE trades at €12.60.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

COP.DE currently has a P/E ratio of 43.58, whereas AJ91.DE's P/E ratio is 10.96. In terms of profitability, COP.DE's ROE is +0.01%, compared to AJ91.DE's ROE of +0.13%. Regarding short-term risk, COP.DE is more volatile compared to AJ91.DE. This indicates potentially higher risk in terms of short-term price fluctuations for COP.DE.Check AJ91.DE's competition here

COP.DE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, COP.DE stands at 1.2B. In comparison, GS9.F has a market cap of 45.6M. Regarding current trading prices, COP.DE is priced at €22.66, while GS9.F trades at €0.13.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

COP.DE currently has a P/E ratio of 43.58, whereas GS9.F's P/E ratio is -0.84. In terms of profitability, COP.DE's ROE is +0.01%, compared to GS9.F's ROE of -0.25%. Regarding short-term risk, COP.DE is more volatile compared to GS9.F. This indicates potentially higher risk in terms of short-term price fluctuations for COP.DE.Check GS9.F's competition here

COP.DE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, COP.DE stands at 1.2B. In comparison, M3V.DE has a market cap of 41.5M. Regarding current trading prices, COP.DE is priced at €22.66, while M3V.DE trades at €22.80.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

COP.DE currently has a P/E ratio of 43.58, whereas M3V.DE's P/E ratio is 13.10. In terms of profitability, COP.DE's ROE is +0.01%, compared to M3V.DE's ROE of +0.13%. Regarding short-term risk, COP.DE is more volatile compared to M3V.DE. This indicates potentially higher risk in terms of short-term price fluctuations for COP.DE.Check M3V.DE's competition here

COP.DE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, COP.DE stands at 1.2B. In comparison, IS8.DE has a market cap of 7.3M. Regarding current trading prices, COP.DE is priced at €22.66, while IS8.DE trades at €2.64.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

COP.DE currently has a P/E ratio of 43.58, whereas IS8.DE's P/E ratio is -0.83. In terms of profitability, COP.DE's ROE is +0.01%, compared to IS8.DE's ROE of +0.05%. Regarding short-term risk, COP.DE is more volatile compared to IS8.DE. This indicates potentially higher risk in terms of short-term price fluctuations for COP.DE.Check IS8.DE's competition here

COP.DE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, COP.DE stands at 1.2B. In comparison, U9O0.F has a market cap of 1.1M. Regarding current trading prices, COP.DE is priced at €22.66, while U9O0.F trades at €0.04.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

COP.DE currently has a P/E ratio of 43.58, whereas U9O0.F's P/E ratio is -2.00. In terms of profitability, COP.DE's ROE is +0.01%, compared to U9O0.F's ROE of +0.17%. Regarding short-term risk, COP.DE is more volatile compared to U9O0.F. This indicates potentially higher risk in terms of short-term price fluctuations for COP.DE.Check U9O0.F's competition here

COP.DE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, COP.DE stands at 1.2B. In comparison, NMI.DE has a market cap of 206.2K. Regarding current trading prices, COP.DE is priced at €22.66, while NMI.DE trades at €0.02.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

COP.DE currently has a P/E ratio of 43.58, whereas NMI.DE's P/E ratio is N/A. In terms of profitability, COP.DE's ROE is +0.01%, compared to NMI.DE's ROE of +0.55%. Regarding short-term risk, COP.DE is more volatile compared to NMI.DE. This indicates potentially higher risk in terms of short-term price fluctuations for COP.DE.Check NMI.DE's competition here

COP.DE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, COP.DE stands at 1.2B. In comparison, MDQK.HM has a market cap of 0. Regarding current trading prices, COP.DE is priced at €22.66, while MDQK.HM trades at €7.50.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

COP.DE currently has a P/E ratio of 43.58, whereas MDQK.HM's P/E ratio is N/A. In terms of profitability, COP.DE's ROE is +0.01%, compared to MDQK.HM's ROE of -0.07%. Regarding short-term risk, COP.DE is less volatile compared to MDQK.HM. This indicates potentially lower risk in terms of short-term price fluctuations for COP.DE.Check MDQK.HM's competition here